For the first time in a decade, obesity in the U.S. is declining — and a new study suggests it’s because of wildly popular medications such as Ozempic.
Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.
The study is one of the largest to investigate the effect of reducing salt in the diet on blood pressure to include people with high blood pressure, also known as hypertension, and already on ...